Evidence map›Paper›PMID 26018859›Full record

ArticleDong wu xue yan jiu = Zoological research2015

Establishment of HIV-1 model cell line GHOST(3) with stable DRiP78 and NHERF1 knockdown.

Lin Zhang, Xu-He Huang, Ping-Ping Zhou, Guo-Long Yu, Jin Yan, Bing Qin, Xin-Ge Yan, Li-Mei Diao, Peng Lin, Yi-Qun Kuang

Open access · greenAbstract read
In one paragraph

Article in Dong wu xue yan jiu = Zoological research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Lin ZhangCenter for Translational Medicine, Huaihe Clinical Institute, Henan University, Kaifeng 475000, China.
Xu-He HuangGuangdong Institute of Public Health and Institute of AIDS Control and Prevention, Guangdong Center for Disease Control and Prevention, Guangzhou 510433, China.
Ping-Ping ZhouGuangdong Institute of Public Health and Institute of AIDS Control and Prevention, Guangdong Center for Disease Control and Prevention, Guangzhou 510433, China.
Guo-Long YuGuangdong Institute of Public Health and Institute of AIDS Control and Prevention, Guangdong Center for Disease Control and Prevention, Guangzhou 510433, China.
Jin YanGuangdong Institute of Public Health and Institute of AIDS Control and Prevention, Guangdong Center for Disease Control and Prevention, Guangzhou 510433, China.
Bing QinGuangdong Institute of Public Health and Institute of AIDS Control and Prevention, Guangdong Center for Disease Control and Prevention, Guangzhou 510433, China.
Xin-Ge YanGuangdong Institute of Public Health and Institute of AIDS Control and Prevention, Guangdong Center for Disease Control and Prevention, Guangzhou 510433, China.
Li-Mei DiaoGuangdong Institute of Public Health and Institute of AIDS Control and Prevention, Guangdong Center for Disease Control and Prevention, Guangzhou 510433, China.
Peng LinGuangdong Institute of Public Health and Institute of AIDS Control and Prevention, Guangdong Center for Disease Control and Prevention, Guangzhou 510433, China.
Yi-Qun KuangCenter for Translational Medicine, Huaihe Clinical Institute, Henan University, Kaifeng 475000, China;Guangdong Institute of Public Health and Institute of AIDS Control and Prevention, Guangdong Center for Disease Control and Prevention, Guangzhou 510433, China. yqkuang@henu.edu.cn.
Guangdong Provincial Center for Disease Control and Prevention · CNCenters for Disease Control and Prevention · USHenan University Huaihe Hospital and Huaihe Clinical Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemokine receptors CXCR4 and CCR5 are indispensable co-receptors for HIV-1 entry into host cells. In our previous study, we identified that dopamine receptor-interacting protein 78 (DRiP78) and Na(+)-H(+) exchanger regulatory factor 1 (NHERF1) are the CXCR4 and CCR5 homo- or hetero-dimer-interacting proteins. DRiP78 and NHERF1 are able to influence the co-receptor internalization and intracellular trafficking. Over-expression of NHERF1 affects the ligands or HIV-1 gp120-induced CCR5 internalization and HIV-1 production. It is reasonable to speculate that DRiP78 and NHERF1, as well as the signaling pathways involved in viral replication, would probably affect HIV-1 replication through regulating the co-receptors. In this present study, we designed two short hairpin RNAs (shRNAs) targeting the DRiP78 and NHERF1, respectively, and constructed the pLenti6/BLOCK-iT-DEST lentiviral plasmids expressing DRiP78 or NHERF1 shRNA. The packaged lentiviruses were used to transduce the widely-applied HIV-1 model cell line GHOST(3). Then, cells with stable knockdown were established through selecting transduced cells with Blasticidin. This study, for the first time, reported the establishment of the GHOST(3) with DRiP78 and NHERF1 knockdown, which is the first stable cell line with HIV-1 co-receptor-interacting molecular defects.

Indexed as

Cell LineFetal ProteinsGene Knockdown TechniquesHIV-1HIV InfectionsHumansMolecular ChaperonesPhosphoproteinsRNA, Small InterferingSodium-Hydrogen ExchangersVirus ReplicationDNAJC14 protein, humanFetal ProteinsMolecular ChaperonesPhosphoproteinsRNA, Small Interferingsodium-hydrogen exchanger regulatory factorSodium-Hydrogen ExchangersDRiP78GHOST(3) cellsHIV-1NHERF1shRNA

Identifiers

PMID26018859
PMCPMC4790691
OpenAlexW2237852016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.